Login / Signup

Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil.

Ida TylleskarArne Kristian SkulbergSissel SkarraTurid NilsenOla Dale
Published in: European journal of clinical pharmacology (2018)
Onset of reversal by IV naloxone was rapid and lasted 118 min. The minimum effective concentration was 0.5 ng/ml. Using TCI remifentanil to obtain a steady-state opioid agonism may be a useful tool to compare new naloxone products.
Keyphrases
  • chronic pain
  • pain management
  • high dose
  • quantum dots